Drug-related deaths are four times more likely to occur in the two days after hospital discharge than at any other time among users of opioids such as heroin, according to research led by UCL, Public Health England (PHE) and King's…
Read More
Disparities in opioid overdose deaths continue to worsen for Black people, study suggests
Non-Hispanic Black individuals in four U.S. states experienced a 38% increase in the rate of opioid overdose deaths from 2018 to 2019, while the rates for other race and ethnicity groups held steady or decreased, according to a new study…
Read More
FDA approves higher dose naloxone hydrochloride nasal spray product to combat opioid overdose
The U.S. Food and Drug Administration announced today the approval of a higher dose naloxone hydrochloride nasal spray product to treat opioid overdose. The newly approved product delivers 8 milligrams (mg) of naloxone into the nasal cavity. The FDA had…
Read More
HHS Loosens Restrictions on Buprenorphine for Opioid Use Disorder
New practice guidelines released by the US Department of Health & Human Services (HHS) remove long-time barriers to buprenorphine for the treatment of opioid use disorder (OUD). Specifically, the Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use…
Read More
Prescription Pad a ‘Lethal Weapon’ for MD Indicted for Murder
A New York physician has been indicted on five counts of murder, with prosecutors alleging he demonstrated a depraved indifference to human life when he prescribed opioids and other drugs to patients who professed substance use disorders and later overdosed….
Read More
Norgesic
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. NORGESIC™ Tablets Orphenadrine citrate 35mg & Paracetamol 450mg Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Norgesic tablets. However it…
Read More
Glucose Intravenous Infusion
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. GLUCOSE INTRAVENOUS INFUSION BP 5% CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about Glucose Intravenous Infusion. It does not contain…
Read More